INNOVIVA, INC. Shares Outstanding (Cover Page)
INNOVIVA, INC. (INVA) had Shares Outstanding (Cover Page) of 72.25 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 72.25M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 73.81M shares.
- 2026-02-13: Entity Common Stock, Shares Outstanding 74.07M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 74.77M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 72.25M shares 10-Q · filed 2026-08-05 |
| 2026-04-30 | 73.81M shares 10-Q · filed 2026-05-06 |
| 2026-02-13 | 74.07M shares 10-K/A · filed 2026-03-27 |
| 2025-10-31 | 74.77M shares 10-Q · filed 2025-11-05 |
| 2025-07-31 | 63.02M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 62.78M shares 10-Q · filed 2025-05-07 |
| 2025-02-14 | 62.68M shares 10-K/A · filed 2025-03-24 |
| 2024-10-31 | 62.60M shares 10-Q · filed 2024-11-06 |
| 2024-07-24 | 62.56M shares 10-Q · filed 2024-07-31 |
| 2024-04-30 | 62.44M shares 10-Q · filed 2024-05-08 |
| 2024-02-14 | 63.23M shares 10-K/A · filed 2024-03-22 |
| 2023-10-26 | 64.09M shares 10-Q · filed 2023-11-01 |
| 2023-07-26 | 65.10M shares 10-Q · filed 2023-08-02 |
| 2023-04-20 | 65.50M shares 10-Q · filed 2023-05-09 |
| 2023-02-14 | 68.13M shares 10-K/A · filed 2023-03-20 |
| 2022-10-28 | 69.78M shares 10-Q · filed 2022-11-09 |
| 2022-07-15 | 69.71M shares 10-Q · filed 2022-07-27 |
| 2022-04-30 | 69.70M shares 10-Q · filed 2022-05-05 |
| 2022-02-14 | 69.57M shares 10-K/A · filed 2022-03-17 |
| 2021-10-18 | 69.49M shares 10-Q · filed 2021-10-27 |
| 2021-07-19 | 69.49M shares 10-Q · filed 2021-07-29 |
| 2021-04-19 | 101.41M shares 10-Q · filed 2021-04-28 |
| 2021-02-12 | 101.39M shares 10-K · filed 2021-02-25 |
| 2020-10-19 | 101.39M shares 10-Q · filed 2020-10-28 |
| 2020-07-20 | 101.39M shares 10-Q · filed 2020-07-29 |
| 2020-04-20 | 101.32M shares 10-Q · filed 2020-04-29 |
| 2020-02-11 | 101.30M shares 10-K/A · filed 2020-02-21 |
| 2019-10-22 | 101.28M shares 10-Q · filed 2019-10-30 |
| 2019-07-17 | 101.28M shares 10-Q · filed 2019-07-24 |
| 2019-04-26 | 101.26M shares 10-Q · filed 2019-05-01 |
| 2019-02-11 | 101.12M shares 10-K · filed 2019-02-19 |
| 2018-10-25 | 101.04M shares 10-Q · filed 2018-10-31 |
| 2018-07-19 | 101.51M shares 10-Q · filed 2018-07-26 |
| 2018-04-30 | 101.47M shares 10-Q · filed 2018-05-04 |
| 2018-02-16 | 101.82M shares 10-K · filed 2018-02-23 |
| 2017-10-31 | 108.02M shares 10-Q · filed 2017-11-03 |
| 2017-07-31 | 109.36M shares 10-Q · filed 2017-08-08 |
| 2017-04-28 | 109.35M shares 10-Q · filed 2017-05-05 |
| 2017-02-24 | 109.20M shares 10-K · filed 2017-02-28 |
| 2016-10-31 | 108.73M shares 10-Q · filed 2016-11-03 |
| 2016-07-31 | 111.20M shares 10-Q · filed 2016-08-04 |
| 2016-04-30 | 113.07M shares 10-Q · filed 2016-05-05 |
| 2016-02-16 | 114.12M shares 10-K · filed 2016-02-24 |
| 2015-10-30 | 117.43M shares 10-Q · filed 2015-11-05 |
| 2015-07-31 | 117.13M shares 10-Q · filed 2015-08-06 |
| 2015-04-30 | 116.87M shares 10-Q · filed 2015-05-08 |
| 2015-02-12 | 116.62M shares 10-K · filed 2015-02-27 |
| 2014-10-31 | 115.37M shares 10-Q · filed 2014-11-04 |
| 2014-07-31 | 115.01M shares 10-Q · filed 2014-08-07 |
| 2014-04-30 | 112.63M shares 10-Q · filed 2014-05-07 |
| 2014-02-14 | 111.98M shares 10-K · filed 2014-03-03 |
| 2013-10-23 | 110.56M shares 10-Q · filed 2013-11-01 |
| 2013-07-24 | 107.24M shares 10-Q · filed 2013-08-01 |
| 2013-04-25 | 99.45M shares 10-Q · filed 2013-05-01 |
| 2013-02-14 | 98.45M shares 10-K · filed 2013-02-26 |
| 2012-10-24 | 97.86M shares 10-Q · filed 2012-10-31 |
| 2012-07-25 | 96.90M shares 10-Q · filed 2012-08-01 |
| 2012-04-25 | 86.54M shares 10-Q · filed 2012-05-02 |
| 2012-02-17 | 86.15M shares 10-K · filed 2012-02-27 |
| 2011-10-26 | 85.13M shares 10-Q · filed 2011-11-02 |
| 2011-07-27 | 84.77M shares 10-Q · filed 2011-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |